The clinical characteristics of neuromyelitis optica spectrum disorders with other autoimmune diseases

doi:10.3969/j.issn.1672-6731.2022.04.012

Abstract

Abstract: Objective To investigate the clinical characteristics of neuromyelitis optica spectrum disorders (NMOSDs) with other autoimmune diseases. Methods and Results Retrospective analysis was performed on 55 NMOSDs patients admitted to Peking University Third Hospital from June 2014 to January 2019. There were 10 NMOSDs patients with autoimmune diseases, including 5 patients with Sj?gren's syndrome (SS), 2 patients with Hashimone's thyroiditis (HT), one patient with rheumatoid arthritis (RA), one patient with systemic lupus erythematosus (SLE), and one patient with undifferentiated connective tissue disease. The proportion of females with autoimmune disease (adjusted χ²=3.842, P=0.050) and positive of anti-AQP4 antibody (adjusted χ²=4.303, P=0.038) was higher than that of females without autoimmune diseases. Among 10 patients of NMOSDs with other autoimmune diseases, 9 patients involved spinal cord, 3 cases only involved cervical spinal, 2 cases only involved thoracic spinal, 4 cases involved both cervical and thoracic spinal at the same time, 4 cases involved optic nerve, one case involved only optic nerve. There was brain lesions in 2 cases, one case involved medulla oblongata. The imaging characteristics of spinal cord lesions were consistent with those of patients with NMOSDs. The length of the lesions were all longer than 3 vertebral bodies, and the longest lesions involved 10 segments. Conclusions NMOSDs is easy to be combined with other autoimmune diseases, which are more common in women, and the rate of positive of anti-AQP4 antibody is higher, which should be paid attention to.

Key words: Neuromyelitis optica, Immune system diseases, Aquaporin 4 Conflicts of interest:none declared

摘要： 目的总结视神经脊髓炎谱系疾病合并其他自身免疫性疾病的临床特点。方法与结果 回顾分析2014年6月至2019年1月北京大学第三医院收治的55例视神经脊髓炎谱系疾病患者,10例合并其他自身免疫性疾病,其中5例合并干燥综合征、2例合并桥本甲状腺炎、1例合并类风湿关节炎、1例合并系统性红斑狼疮、1例合并未分化结缔组织病。合并自身免疫性疾病组女性(校正χ²=3.842,P=0.050)和抗AQP4抗体阳性(校正χ²=4.303,P=0.038)比例高于未合并自身免疫性疾病组。10例合并其他自身免疫性疾病患者中9例脊髓受累,其中颈髓3例、胸髓2例、颈髓和胸髓4例,4例视神经受累,其中单纯视神经受累仅1例,2例存在脑部病灶,1例延髓受累。脊髓病灶的影像学特点符合视神经脊髓炎谱系疾病,病变节段> 3个椎体长度,最长累及10个节段。结论视神经脊髓炎谱系疾病易合并其他自身免疫性疾病,以女性多见,抗AQP4抗体阳性率更高,应引起重视。

关键词: 视神经脊髓炎, 免疫系统疾病, 水通道蛋白质 4

SUN Qing-li, MA Yan, FAN Dong-sheng. The clinical characteristics of neuromyelitis optica spectrum disorders with other autoimmune diseases[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(4): 300-305.

孙庆利, 马妍, 樊东升. 视神经脊髓炎谱系疾病合并其他自身免疫性疾病临床特点分析[J]. 中国现代神经疾病杂志, 2022, 22(4): 300-305.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2022.04.012

https://journal11.magtechjournal.com/cjcnn/EN/Y2022/V22/I4/300

References

[1] Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG;International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85:177-189.
[2] Freitas E, Guimar?es J. Neuromyelitis optica spectrum disorders associated with other autoimmune diseases[J]. Rheumatol Int, 2015, 35:243-253.
[3] Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A. Autoimmune diseases associated with neuromyelitis optica spectrum disorders:a literature review[J]. Mult Scler Relat Disord, 2019, 27:350-363.
[4] Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schi?dt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T;Sj?gren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sj?gren's syndrome:a data-driven, expert consensus approach in the Sj?ren's International Collaborative Clinical Alliance cohort[J]. Arthritis Care Res (Hoboken), 2012, 64:475-487.
[5] Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League against Rheumatism Collaborative Initiative[J]. Arthritis Rheum, 2010, 62:2569-2581.
[6] Endocrinology Branch, Chinese Medical Association, Compiled group of the Guide for Diagnosis and Treatment of Thyroid Diseases. Guide for diagnosis and treatment of thyroid diseases in China:thyroiditis[J]. Zhonghua Nei Ke Za Zhi, 2008, 47:784-788.[中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺炎[J].中华内科杂志, 2008, 47:784-788.]
[7] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40:1725.
[8] Berkowitz AL, Samuels MA. The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis[J]. Pract Neurol, 2014, 14:14-22.
[9] Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA. Sj?gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu[J].Arq Neuropsiquiatr, 2014, 72:619-624.
[10] Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity[J]. Arch Neurol, 2008, 65:78-83.
[11] Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome[J]. Curr Opin Neurol, 2010, 23:509-513.
[12] Sá MJ. Acute transverse myelitis:a practical reappraisal[J].Autoimmun Rev, 2009, 9:128-131.
[13] Qiao L, Luo Y, Zhang LL, Zhao LD, Wang Q, Xu Y, Zhao Y. The clinical characteristics of primary Sjogren syndrome with neuromyelitis optica[J]. Zhonghua Nei Ke Za Zhi, 2013, 52:745-748.
[14] Lalji A, Izbudak I, Birnbaum J. Cortical blindness and not optic neuritis as a cause of vision loss in a Sj?gren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD):challenges of ascribing demyelinating syndromes to SS:a case report[J]. Medicine (Baltimore), 2017, 96:e7454.
[15] Sawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N. A case of pathology-proven neuromyelitis optica spectrum disorder with Sj?gren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion[J]. Mult Scler, 2014, 20:1413-1416.
[16] Park JH, Hwang J, Min JH, Kim BJ, Kang ES, Lee KH. Presence of anti-Ro/SSA antibody may be associated with antiaquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder[J]. J Neurol Sci, 2015, 348:132-135.
[17] Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Kuwabara S. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica[J]. Eur J Neurol, 2016, 23:276-281.
[18] Zhong YH, Zhong ZG, Zhou Z, Ma ZY, Qiu MY, Peng FH, Zhang WX. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sj?gren's syndrome[J]. Neurol Sci, 2017, 38:271-277.
[19] Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis[J]. Mult Scler, 2008, 14:809-814.
[20] Long Y, Liang J, Wu L, Lin S, Gao C, Chen X, Qiu W, Yang Y, Zheng X, Yang N, Gao M, Chen Y, Wang Z, Su Q. Different phenotypes at onset in neuromyelitis optica spectrum disorder patients with aquaporin-4 autoimmunity[J]. Front Neurol, 2017, 8:62.
[21] Estiasari R, Matsushita T, Masaki K, Akiyama T, Yonekawa T, Isobe N, Kira J. Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren's syndrome patients with central nervous system manifestations[J]. Mult Scler, 2012, 18:807-816.
[22] Li H, Dai Y, Wu AM, Sun X, Lin Y, Lv K, Lu Z. Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders[J]. J Neuroimmunol, 2015, 281:38-43.
[23] Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus:a predominantly population-based study[J]. Mult Scler, 2018, 24:331-339.
[24] Zhang S, Wang Z, Zhao J, Wu DI, Li J, Wang Q, Su J, Xu D, Wang Y, Li M, Zeng X. Clinical features of transverse myelitis associated with systemic lupus erythematosus[J]. Lupus, 2020, 29:389-397.
[25] Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis[J]. Ann Neurol, 2006, 59:566-569.
[26] Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO:a study on antibody titre[J]. Brain, 2007, 130(Pt 5):1235-1243.

Please choose a citation manager

Content to export